144 related articles for article (PubMed ID: 493090)
21. [Interferon].
Schürmann W
Krankenpfl J; 1981 Aug; 19(8):16-8. PubMed ID: 6169876
[No Abstract] [Full Text] [Related]
22. [Interferons].
Haahr S
Ugeskr Laeger; 1977 Feb; 139(7):411-2. PubMed ID: 841728
[No Abstract] [Full Text] [Related]
23. Inexpensive interferon therapy of cancer and the viral diseases now.
Stone I
Australas Nurses J; 1981 Mar; 10(3):25-8. PubMed ID: 6166295
[No Abstract] [Full Text] [Related]
24. [Interferon: biosynthesis, characteristics and mechanism of action].
Bodo G
Wien Klin Wochenschr; 1969 Aug; 81(31):571-6. PubMed ID: 4999050
[No Abstract] [Full Text] [Related]
25. [Stimulation of interferon formation in animals and humans and the obtainment of donor plasma containing interferon for clinical parenteral use].
Skurkovich SV; Sabashvili MK
Probl Gematol Pereliv Krovi; 1971 Jun; 16(6):11-4. PubMed ID: 5119056
[No Abstract] [Full Text] [Related]
26. [Interferon therapy in virus infections].
Wadell G
Lakartidningen; 1977 Dec; 74(51):4593-7. PubMed ID: 599986
[No Abstract] [Full Text] [Related]
27. [Viruses and interferon].
Regnard J; Bricout F
Cah Med; 1972 Dec; 13(15):1049-55. PubMed ID: 4350494
[No Abstract] [Full Text] [Related]
28. Interferon sensitivity and inducibility by acute hemorrhagic conjunctivitis viruses.
Stanton GJ; Langford MP
Tex Rep Biol Med; 1977; 35():501-10. PubMed ID: 211669
[No Abstract] [Full Text] [Related]
29. The interferon system as a basis for antiviral therapy or prophylaxis.
Billiau A
Verh K Acad Geneeskd Belg; 1986; 48(3):187-220. PubMed ID: 2430375
[No Abstract] [Full Text] [Related]
30. Current concepts of interferon and interferon induction.
De Clercq E; Merigan TC
Annu Rev Med; 1970; 21():17-46. PubMed ID: 4912475
[No Abstract] [Full Text] [Related]
31. The interferons and their inducers: molecular and therapeutic considerations. 3.
Grossberg SE
N Engl J Med; 1972 Jul; 287(3):122-8. PubMed ID: 4555741
[No Abstract] [Full Text] [Related]
32. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
Billiau A
J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
[TBL] [Abstract][Full Text] [Related]
33. [The interferon system and its significance for virus disease therapy].
Ho M
Verh Dtsch Ges Inn Med; 1969; 75():612-8. PubMed ID: 5401589
[No Abstract] [Full Text] [Related]
34. [Interferon as a therapeutic agent].
Borecký L
Cesk Farm; 1982 Jun; 31(5):184-7. PubMed ID: 6180842
[No Abstract] [Full Text] [Related]
35. Interferon options.
Br Med J; 1977 Jan; 1(6053):64-5. PubMed ID: 832014
[No Abstract] [Full Text] [Related]
36. Interferon.
Lancet; 1971 Mar; 1(7699):586. PubMed ID: 4100912
[No Abstract] [Full Text] [Related]
37. The interferons--clinical applications and new technologies.
Witherspoon LR
J Nucl Med; 1984 Jul; 25(7):817-21. PubMed ID: 6204027
[No Abstract] [Full Text] [Related]
38. [Artificial polynucleotides as inducers of interferon].
Heidel G
Z Gesamte Hyg; 1974 Feb; 20(2):116. PubMed ID: 4598964
[No Abstract] [Full Text] [Related]
39. General considerations of the interferon system.
Baron S; Dianzani F
Tex Rep Biol Med; 1977; 35():1-10. PubMed ID: 616665
[No Abstract] [Full Text] [Related]
40. [Interferon, its properties and perspectives for its practical use].
Smorodintsev A
Usp Sovrem Biol; 1966; 62(3):398-414. PubMed ID: 4881796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
